Endocrine regulation of lung disease and inflammation

Exp Biol Med (Maywood). 2018 Dec;243(17-18):1313-1322. doi: 10.1177/1535370218816653. Epub 2018 Dec 3.

Abstract

Sex-differences in the incidence and severity of inflammatory lung diseases have been recognized for years. Women of reproductive age are more likely to suffer from chronic lung disease, with higher mortality rates than men. Physiological changes in hormone levels such as those occurring during the menstrual cycle, pregnancy, and menopause have been associated with lung function changes and asthma symptoms. Despite this, the roles of sex hormones in the mechanisms associated with lung diseases have not been fully elucidated. This review summarizes basic and clinical studies of sex hormones as potential modulators of lung function and inflammation. The information obtained from sex-specific research on lung physiology and pathology will potentially help in the development of sex-specific therapeutics for inflammatory lung disease that may account for the hormonal status of the patient.

Keywords: Sex differences; asthma; hormone; inflammation; lung disease; lung immunity.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Asthma / metabolism*
  • Asthma / pathology
  • Female
  • Gonadal Steroid Hormones / metabolism*
  • Humans
  • Inflammation / metabolism
  • Inflammation / pathology
  • Male
  • Menopause
  • Menstrual Cycle
  • Pregnancy
  • Sex Characteristics*

Substances

  • Gonadal Steroid Hormones